PVRI International Conference 2025: Embracing Heterogeneity

PVRI International Conference 2025: Embracing Heterogeneity

Saved in:

Bibliographic Details
Main Authors:	Navneet Singh, Katarina Zeder
Format:	Article
Language:	English
Published:	Wiley 2025-04-01
Series:	Pulmonary Circulation
Subjects:	conference pulmonary hypertension pulmonary vascular research institute
Online Access:	https://doi.org/10.1002/pul2.70093
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Epidemiology, Burden, Risk Factors, Presentations, and Challenges of Evaluating and Managing Patients with Pulmonary Hypertension in Nigeria – A Short Review
by: Oluwafemi Tunde Ojo, et al.
Published: (2024-12-01)

The Heterogeneity of Pulmonary Hypertension Nomenclature in Empiric Research Studies: Systematic Findings From Three Western European Countries
by: Armella Santi, et al.
Published: (2025-04-01)

The pulmonary resistance‐compliance relationship: Real or mathematical artifact?
by: Sara Hungerford, et al.
Published: (2025-05-01)

A novel dual fixation method for improving the reliable assessment of pulmonary vascular morphology in pulmonary hypertension rats
by: Yan Xu, et al.
Published: (2025-01-01)

Editorial: Exploring the role of epigenetic modifications in pulmonary vascular disease pathogenesis
by: Sasha Z. Prisco, et al.
Published: (2025-05-01)

Intravascular ultrasound evaluation of pulmonary hypertension in high-altitude patients with ventricular septal defect: a case report
by: Yuanguo Chen, et al.
Published: (2025-06-01)

Pulmonary hypertension associated with neurofibromatosis type 2
by: Hirohisa Taniguchi, et al.
Published: (2021-07-01)

Difference in efficacy between pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
by: Kenichi Yanaka, et al.
Published: (2025-08-01)

Pulmonary artery aneurysm as a rare manifestation of Alpha-1 antitrypsin deficiency
by: Mark A. Colantonio, et al.
Published: (2025-01-01)

What’s new in pulmonary hypertension clinical research: lessons from the best abstracts at the 2020 American Thoracic Society International Conference
by: Andrew J. Sweatt, et al.
Published: (2021-07-01)

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021)
by: I. E. Chazova, et al.
Published: (2022-05-01)

Performance of Risk‐Stratification Scores for Patients With Pulmonary Arterial Hypertension in a Multi‐Ethnic Asian Population
by: Haowen Jiang, et al.
Published: (2025-01-01)

Level 3 Cardiopulmonary Exercise Testing to Guide Therapeutic Decisions in Non-Severe Pulmonary Hypertension with Lung Disease
by: Raj Parikh, et al.
Published: (2025-07-01)

Balloon Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
by: Lauren N. Carlozzi, et al.
Published: (2024-05-01)

Role of Extracellular Vesicles in Chronic Post-Embolic Pulmonary Hypertension: Data from an Experimental Animal Model and Patients
by: Elva Mendoza-Zambrano, et al.
Published: (2025-06-01)

T follicular helper cell is essential for M2 macrophage polarization and pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension
by: Cheng Li, et al.
Published: (2024-12-01)

Porto-Pulmonary Hypertension and Hepato-Pulmonary Syndrome: Diagnostic Procedures and Therapeutic Management
by: Roberto G. Carbone, et al.
Published: (2025-07-01)

PULMONARY HYPERTENSION: DIFFICULT CASE IN CLINICAL PRACTICE
by: D. V. Madeeva, et al.
Published: (2014-07-01)

Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double‐blind placebo‐controlled study
by: Dunbar Ivy, et al.
Published: (2021-07-01)

Baseline pulmonary hypertension in heart transplant recipients: 9 years of experience at Almazov National Medical Research Centre
by: M. A. Simonenko, et al.
Published: (2020-02-01)

Research-to-practice conference as a component of improving knowledge and mastering professional competencies by medical students and young scientists
by: V. N. Larina, et al.
Published: (2024-02-01)

Importance of age at diagnosis of pulmonary hypertension in children living at high altitude: Longitudinal follow‐up of 86 patients
by: Gabriel F. Diaz, et al.
Published: (2025-04-01)

Emerging Mechanistic Insights and Therapeutic Strategies for Pulmonary Arterial Hypertension: A Focus on Right Ventricular Dysfunction and Novel Treatment Pathways
by: Masab Mansoor, et al.
Published: (2025-03-01)

Sarcopenia in Patients with Chronic Thromboembolic Pulmonary Hypertension
by: Steven Hopkins, et al.
Published: (2025-04-01)

CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: NEW ASPECTS OF THE DEVELOPMENT AND PROGRESSION OF THE DISEASE
by: A. A. Klimenko, et al.
Published: (2014-07-01)

Interpretation on the Guidelines for the Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension(2024 edition)
by: YANG Furong, et al.
Published: (2025-05-01)

The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension
by: Anggoro Budi Hartopo, et al.
Published: (2017-08-01)

The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension
by: Anggoro Budi Hartopo, et al.
Published: (2017-08-01)

The multidisciplinary management of pulmonary arterial hypertension patients in pregnancy and postpartum: A case series
by: Jasmine N. Edghill, et al.
Published: (2025-07-01)

Pulmonary thromboendarterectomy in pediatric patients: Report of three cases
by: Ulaş Kumbasar, et al.
Published: (2018-10-01)

Pulmonary vascular anomalies: a review of clinical and radiological findings of cases presenting with different complaints in childhood
by: Hikmet Tekin Nacaroğlu, et al.
Published: (2016-06-01)

Pulmonary Vein Varix: A Diagnostic Enigma
by: Madhuri Howdekar, et al.
Published: (2023-12-01)

Revisiting hemodynamic definition: Incidence of chronic thromboembolic pulmonary hypertension following acute intermediate-high and high-risk pulmonary embolism
by: Bárbara Lacerda Teixeira, et al.
Published: (2024-12-01)

Prognosis and Treatment With Phosphodiesterase 5 Inhibitors in Combined Post‐ and Precapillary Pulmonary Hypertension: A Propensity Score‐Matched Analysis From the Hellenic Pulmonary Hypertension Registry
by: Georgios E. Papadopoulos, et al.
Published: (2025-04-01)

Zhishi Xiebai Guizhi Decoction modulates hypoxia and lipid toxicity to alleviate pulmonary vascular remodeling of pulmonary hypertension in rats
by: Min Fu, et al.
Published: (2024-12-01)

CASE REPORT ON THE SUCCESSFUL USE OF A NEW SELECTIVE PROSTACYCLIN IP RECEPTOR AGONIST, SELEXIPAG, IN A PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2019-12-01)

THE EFFICIENCY OF BOSENTAN BASED ON THE DATA OF THE REGISTER OF PATIENTS WITH PULMONARY HYPERTENSION IN THE VORONEZH REGION
by: O. M. Korolkova
Published: (2017-06-01)

EFFECTIVENESS OF ILOPROST IN PATIENTS WITH PULMONARY HYPERTENSION FC III - IV BASED ON VORONEZH REGION REGISTRY DATA
by: O. M. Korolkova, et al.
Published: (2019-06-01)

CLINICAL CASE OF REPLACEMENT OF ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) BY SOLUBLE GUANYLATE CYCLASE STIMULATOR (RIOCIGUAT) IN THE PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
by: E. A. Devetyarova, et al.
Published: (2018-06-01)

Comparative Histopathological Evaluation of Pulmonary Arterial Remodeling in Fatal COVID-19 and H1N1 Influenza Autopsy Cases
by: Sergiy G. Gychka, et al.
Published: (2025-05-01)